These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 11033355

  • 1. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 2. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct 13; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 3. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 4. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
    De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V.
    J Biol Chem; 2001 Apr 20; 276(16):12856-63. PubMed ID: 11278420
    [Abstract] [Full Text] [Related]

  • 5. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 6. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D.
    Br J Anaesth; 2002 Dec 19; 89(6):882-7. PubMed ID: 12453933
    [Abstract] [Full Text] [Related]

  • 7. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb 25; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 9. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 2002 Mar 25; 300(3):984-91. PubMed ID: 11861807
    [Abstract] [Full Text] [Related]

  • 10. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V.
    Biochem Pharmacol; 2003 May 01; 65(9):1473-81. PubMed ID: 12732359
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V.
    J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100
    [Abstract] [Full Text] [Related]

  • 12. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L.
    FEBS Lett; 1998 Oct 09; 436(3):449-54. PubMed ID: 9801167
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, Smart D.
    Eur J Pharmacol; 2001 Jul 27; 424(3):211-9. PubMed ID: 11672565
    [Abstract] [Full Text] [Related]

  • 14. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
    De Petrocellis L, Davis JB, Di Marzo V.
    FEBS Lett; 2001 Oct 12; 506(3):253-6. PubMed ID: 11602256
    [Abstract] [Full Text] [Related]

  • 15. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
    Roberts LA, Christie MJ, Connor M.
    Br J Pharmacol; 2002 Oct 12; 137(4):421-8. PubMed ID: 12359623
    [Abstract] [Full Text] [Related]

  • 16. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
    Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):121-5. PubMed ID: 11448475
    [Abstract] [Full Text] [Related]

  • 17. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide.
    Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA.
    J Physiol; 2001 Aug 01; 534(Pt 3):813-25. PubMed ID: 11483711
    [Abstract] [Full Text] [Related]

  • 18. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.
    Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, Bianchi A.
    J Neurosci; 2001 Feb 15; 21(4):1104-9. PubMed ID: 11160380
    [Abstract] [Full Text] [Related]

  • 19. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
    Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB.
    Br J Pharmacol; 2000 Jan 15; 129(2):227-30. PubMed ID: 10694225
    [Abstract] [Full Text] [Related]

  • 20. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase.
    De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V.
    J Neurochem; 2001 Jun 15; 77(6):1660-3. PubMed ID: 11413249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.